NCT04190186View on ClinicalTrials.gov

Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 25, 2020

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Insertable Cardiac Monitor

Implantable device that provides accurate daily transmission of cardiac electrical data for arrhythmia detection.

Trial Locations (4)

14621

Rochester Regional Health, Rochester

14642

University of Rochester, Rochester

38801

Cardiology Associates Research, LLC, Tupelo

48197

Michigan Heart, PC, Ypsilanti

Sponsors

Collaborators (1)

Biotronik, Inc.
All Listed Sponsors
collaborator

Biotronik, Inc.

INDUSTRY

lead

University of Rochester

OTHER